The number of known genetic markers of risk \\nis increasing but the interpretation of their \\nclinical effect is hampered by poor reporting \\nof prediction studies. These guidelines from \\nthe GRIPS group aim to ensure transparent \\nreporting of prediction studies
A. Cecile J.W. Janssens, John P A Ioannidis, Sara Bedrosian, Paolo Boffetta, Siobhan M. Dolan, Nicole F. Dowling, Isabel Fortier, Andrew N. Freedman, Jeremy Grimshaw, Jeffrey R. Gulcher, Marta Gwinn, Mark A. Hlatky, Holly Janes, Peter Kraft, Stephanie Melillo, Christopher J. O’Donnell, Michael Pencina, David F. Ransohoff, Sheri D. Schully, Daniela Seminara, Deborah M. Winn, Caroline F. Wright, Cornelia M. van Duijn,
A. Cecile J.W. Janssens, John P A Ioannidis, Sara Bedrosian, Paolo Boffetta, Siobhan M. Dolan, Nicole F. Dowling, Isabel Fortier, Andrew N. Freedman, Jeremy Grimshaw, Jeffrey R. Gulcher, Marta Gwinn, Mark A. Hlatky, Holly Janes, Peter Kraft, Stephanie Melillo, Christopher J. O’Donnell, Michael Pencina, David F. Ransohoff, Sheri D. Schully, Daniela Seminara, Deborah M. Winn, Caroline F. Wright, Cornelia M. van Duijn,
Discussion(0)
No comments yet. Be the first to comment.